Ebenhoch, Rebecca http://orcid.org/0000-0003-4304-7434
Akhdar, Abbas
Reboll, Marc R.
Korf-Klingebiel, Mortimer
Gupta, Priyanka http://orcid.org/0000-0001-6483-3069
Armstrong, Julie
Huang, Yining
Frego, Lee
Rybina, Irina
Miglietta, John
Pekcec, Anton
Wollert, Kai C.
Nar, Herbert
Article History
Received: 13 August 2019
Accepted: 4 November 2019
First Online: 26 November 2019
Competing interests
: R.E., P.G., J.A., Y.H., L.F., I.R., J.M., A.P. and H.N. were full-time employees of Boehringer Ingelheim at the time this study was performed. M.K.-K. and K.C.W. hold a patent and entered a collaborative agreement with Boehringer Ingelheim covering the therapeutic use of MYDGF in cardiovascular disease. The other authors declare no competing interests.